Evidence map›Paper›PMID 40998845›Full record

ArticleScientific reports2025

Association between exacerbation history and airway bacterial community assessed by extended bacterial culture and sequencing approaches in stable COPD.

Quentin Lecomte-Thenot, Jeanne-Marie Perotin, Geneviève Héry-Arnaud, Lourdes Vélo-Suarez, Audrey Brisebarre, Alice Clarenne, Stéphanie Gouriou, Sandra Dury, Gaëtan Deslée, Anaëlle Muggeo and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Quentin Lecomte-ThenotUniversité de Reims Champagne-Ardenne, INSERM, CHU de Reims, Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, P3Cell, U 1250, Reims, France.
Jeanne-Marie PerotinUniversité de Reims Champagne-Ardenne, INSERM, CHU de Reims, Service des Maladies Respiratoires, P3Cell, U 1250, Reims, France.
Geneviève Héry-ArnaudCentre Brestois d'Analyse du Microbiote (CBAM), CHRU de Brest, Brest, France.
Lourdes Vélo-SuarezUniv Brest, Inserm, EFS, UMR 1078, GGB, 29200, Brest, France.
Audrey BrisebarreUniversité de Reims Champagne-Ardenne, INSERM, P3Cell, U 1250, Reims, France.
Alice ClarenneUniversité de Reims Champagne-Ardenne, INSERM, CHU de Reims, Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, P3Cell, U 1250, Reims, France.
Stéphanie GouriouUniversité de Brest, Inserm, UMR 1078, Unité de Bactériologie, CHRU de Brest, 29200, Brest, France.
Sandra DuryService des Maladies Respiratoires, Université de Reims Champagne-Ardenne, EA7509 IRMAIC, CHU de Reims, Reims, France.
Gaëtan DesléeUniversité de Reims Champagne-Ardenne, INSERM, CHU de Reims, Service des Maladies Respiratoires, P3Cell, U 1250, Reims, France.
Anaëlle MuggeoUniversité de Reims Champagne-Ardenne, INSERM, CHU de Reims, Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, P3Cell, U 1250, Reims, France.
Thomas GuillardUniversité de Reims Champagne-Ardenne, INSERM, CHU de Reims, Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, P3Cell, U 1250, Reims, France. tguillard@chu-reims.fr.
RINNOPARI Study Group includes

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms due to abnormalities of the airways and/or alveoli that cause airflow obstruction. It is a leading cause of death worldwide. While alterations in airway bacterial community have been linked to exacerbation frequency, the underlying mechanisms remain unclear. We aimed to characterize associations between airway bacterial community structure and exacerbation history in stable COPD patients and to identify candidate microbial markers that could assist in risk assessment for the clinical management of COPD patients. Sixty-two stable COPD patients were enrolled and categorized into two groups based on their exacerbation history: low risk (LR) and high risk (HR) of exacerbation. Sputum samples were collected and analyzed using both bacterial extended culture and 16S rRNA gene sequencing. The combination of these approaches provided complementary insights, enabling a more comprehensive characterization of the bacterial community. To our knowledge, this is the first study to combine these two approaches in this context and to evaluate their relative performance in detecting microbiological markers associated with exacerbation risk. Microbial composition analysis revealed a loss of α-diversity in HR patients based on extended culture data, a finding not corroborated by sequencing. This discrepancy suggests that the observed impoverishment of diversity may primarily affect the viable fraction of the airway microbial community. The HR group also exhibited increased relative abundances of Pseudomonadota and Bacteroidota, alongside a marked decrease in relative abundances of Lactobacillus and Streptococcus. Notably, significant reductions in the proportion of positive samples were observed at the species level for Streptococcus salivarius and Streptococcus mutans. A comparison of the two methods underlined that 16S rRNA gene sequencing identified five additional phyla and 84 genera not detected by culture, notably strict anaerobes. However, extended culture demonstrated robust sensitivity in detecting Enterobacterales and the pathogenic Moraxella and Pseudomonas. This study revealed microbiological features linked to exacerbation history in stable COPD patients, highlighting the need for future functional and longitudinal research to validate these airway bacterial community signatures and develop targeted preventive strategies.

Indexed as

BacteriaMicrobiotaPulmonary Disease, Chronic ObstructiveAgedDisease ProgressionFemaleHumansMaleMiddle AgedRNA, Ribosomal, 16SSputumRNA, Ribosomal, 16S16S rRNA gene sequencingBacterial communityCOPD - chronic obstructive pulmonary diseaseExacerbation riskExtended cultureMicrobiotaSputumStable state

Identifiers

PMID40998845
PMCPMC12464265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.